All Industries

Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd

QNTM

As the health and wellness sector gains momentum, consumers are increasingly seeking products that can aid recovery from the effects of alcohol. Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM), a company focused on developing innovative health solutions, is well-positioned to meet this demand with its groundbreaking product designed to support the body in metabolizing alcohol. Recently, Quantum BioPharma announced a significant business development. On October 7, 2024, its subsidiary, Celly Nutrition Corp, secured a Master Distribution Agreement with FUSION Consulting Group. This agreement could have meaningful implications for the company as it expands the market for its alcohol metabolism product, unbuzzd. The News: Expanding Market Reach Celly Nutrition’s partnership with FUSION, a distributor operating across Puerto Rico, the Caribbean, and parts of Central and South America, could signal a key turning point for Unbuzzd, a product designed to support the body’s natural alcohol metabolization processes. By entering major vacation destinations known for high alcohol consumption, the product will now be distributed through prominent retailers, including Walmart, Walgreens, CVS, Costco, and others. John Duffy, CEO of Celly Nutrition, emphasized the importance of this partnership, stating: “Our partnership with FUSION marks a pivotal moment for Unbuzzd. Their proven success in growing brands across the region will help us expand our footprint while delivering a functional, science-backed product.” Currently available on Amazon in Ready-to-Mix powder sticks, Unbuzzd is also set to launch in Ready-to-Drink 12oz cans. FUSION’s experience distributing other health-conscious beverages like CELSIUS and SHINE Water provides Celly Nutrition with a strategic partner to help Unbuzzd gain traction in these new markets. Why This Matters This development comes at a time when Quantum BioPharma is actively expanding its business model beyond its core focus in biopharmaceuticals. While the company’s primary drug candidate, Lucid-MS, remains in the preclinical stage, Quantum BioPharma’s stake in Celly Nutrition provides a diversification strategy with potential for near-term revenue generation. By retaining a 25.71% ownership stake in Celly Nutrition, Quantum BioPharma is positioned to benefit from any financial success Unbuzzd achieves, with royalties further boosting revenue. Celly Nutrition’s Unbuzzd stands out in the growing wellness and recovery market, offering a solution to help metabolize alcohol faster, promoting clarity, and minimizing aftereffects. With FUSION’s established distribution network, Unbuzzd, now has the opportunity to reach a wider audience, including consumers who may prioritize wellness while still enjoying alcohol responsibly. Eduardo Santacana, CEO of FUSION Consulting Group, expressed enthusiasm about the partnership, stating: “It’s an exciting opportunity to be part of Unbuzzd’s journey. This innovative product helps metabolize alcohol faster, promoting clarity and minimizing the aftereffects of drinking.” With the product entering new markets and retail giants like Walmart and Costco, Unbuzzd’s potential for broad consumer adoption increases, which could contribute meaningfully to Quantum BioPharma’s future financial performance. This partnership underscores Quantum BioPharma’s strategy to diversify and expand its revenue streams. Although the company remains committed to advancing its biopharmaceutical pipeline, particularly with the development of Lucid-MS, its involvement in Celly Nutrition offers a complementary business avenue in the wellness space. As Unbuzz gains traction in markets known for high tourist activity, Quantum BioPharma stands to benefit from the increased visibility and sales that FUSION’s network could generate. The company’s decision to remain invested in Celly Nutrition suggests confidence in the product’s potential to deliver near-term returns. If Unbuzzd continues to resonate with consumers in these key markets, it could help bolster Quantum BioPharma’s financial performance in a way that supports its long-term biopharma ambitions. Conclusion: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) has taken an important step in expanding its business with Celly Nutrition’s Master Distribution Agreement. This partnership with FUSION Consulting Group has the potential to introduce Unbuzzd to new markets and drive significant sales, complementing Quantum BioPharma’s ongoing drug development efforts. With the potential for sales growth and diversification of its revenue streams, QNTM could emerge as a compelling stock to monitor in the evolving health and wellness market. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

October 15, 2024 06:00 AM Eastern Daylight Time

News Release

Sergiy Groza and Volodymyr Naumenko sentenced to prison by English High Court Judge

Argentem Creek Partners

Sergiy Groza and Volodymyr Naumenko, former ultimate beneficial owners of GN Terminal Enterprises, sentenced to 21 months in prison by English High Court judge, Mr. Justice Bryan. Groza and Naumenko breached an asset disclosure order, made in support of a worldwide freezing order (“WFO”). London, UK, 15 October 2024 – The former ultimate beneficial owners (“UBO”) of the Ukrainian import-export business GN Terminal Enterprises (“GNT”), Sergiy Groza and Volodymyr Naumenko, have been sentenced to 21 months in prison by a judge of the English High Court for failing to comply with a worldwide freezing order (“WFO”). Groza and Naumenko were found to be in contempt of court by Mr Justice Bryan during a committal hearing on Friday, 30th August for breaching an asset disclosure order made in support of the WFO, before being sentenced on Friday 4 th October 2024. The disclosure order was made in April 2024, pursuant to the US$118 million English High Court WFO over Groza and Naumenko’s assets, in order for Madison Pacific Trust Limited to be able to police Groza and Naumenko’s compliance with the WFO. But the Ukrainian businessmen actively refused not to comply with the disclosure order, which has ultimately led to their committal for contempt of court (to the criminal burden of proof) and them being sentenced to prison. Groza attended the sentencing hearing remotely, but did not respond when asked by the Judge if he wished to say anything in his defence, despite being given the use of a Ukrainian translator, while Naumenko did not appear at all. Mr Justice Bryan issued warrants of committal for Groza and Naumenko meaning they will be arrested when they next set foot in the United Kingdom. Nicholas Cherryman, a barrister instructed by Groza and Naumenko only the night before the hearing, requested an adjournment which was rejected by Mr Justice Bryan. The judge condemned the late appointment of lawyers (which was only notified to the court an hour before the sanction hearing commenced) as “the hallmarks of a last minute ploy to secure an adjournment.” Groza and Naumenko are represented by Fortior Law SA, Solsidus Law, Appleby and M.B. Kemp LLP in various proceedings around the world. The WFO was originally obtained by Madison Pacific on behalf of GNT’s secured lenders, Argentem Creek Partners (“ACP”) and Innovatus Capital Partners (“Innovatus”), in January 2023. It was upheld after an unsuccessful challenge by Groza and Naumenko in February 2024. The presiding judge, Mr Justice Jacobs, stated that he was concerned about the “very real risk of dissipation [of assets].” He added that the asset dissipation case is “one where the evidence is as strong as any that I have ever seen.” The disclosure order required Groza and Naumenko to provide further information about US$97 million of dividends received over a 10-year period from their shareholding in GNT; nominees holding their assets; and funding of their legal fees in these and related proceedings via Waylink Assets, a company owned by Groza. Mr Justice Bryan, Judge of the Commercial Court, noted in his sentencing that “I am satisfied that the Claimant continues to suffer very real prejudice as every day goes by when the Defendants continue to fail to comply with the Disclosure Order the very purpose of which is to police the freezing injunction.” He also noted that an 80-page witness statement submitted by Naumenko shortly before the committal hearing highlighted “the lengths to which [Groza and Naumenko] have gone to fight and, the Claimants would say, seek to frustrate, the Claimant's debt enforcement steps around the world.” He also referred back to the "fierce resistance" Mr Justice Jacobs found in his judgment upholding the WFO. Daniel Chapman, CEO and founder of Argentem Creek Partners, commented: “Any entity, private or public, which is working with Groza and Naumenko should stop conducting business with these bad actors. Case after case in Ukraine and across the world have laid out the truth: Groza and Naumenko are flagrantly breaking the law and ignoring court orders. With them now being sentenced to prison in England, it is the time for legitimate businesses and local government entities alike to truly stand up for the rule of law. Facilitating unlawful behavior cannot be tolerated at any level.” John Patton, Head of EMEA & Asia at Argentem Creek Partners, said: "This is a step toward justice. The decision by the English High Court reinforces that Sergiy Groza and Volodymyr Naumenko have continued to break the law for personal gain. They have consistently taken deliberate steps to hide and strip their assets from GNT Group and avoid disclosure of any information even when ordered by competent courts. Finally, they are being held responsible for their actions. “At a time when Ukraine needs its companies to pay taxes in full and support the country’s war effort, Groza and Naumenko are hiding millions of dollars offshore, using a company run by Russian citizen, Mikhail Ipatov.” Ana Firmato, Managing Director at Innovatus, added: “Justice Bryan’s decision is clear and unequivocal. Sergiy Groza and Volodymyr Naumenko have consistently and deliberately exploited the law for personal and financial gain, and this sentencing holds them accountable for their repeated wrongdoing. We appreciate the support of the English High Court and look forward to bringing the former ultimate beneficial owners of GNT to justice." In 2019, ACP provided a US$75 million loan to GNT Group under a secured English law facility agreement. This loan benefits from security over the majority of GNT's assets and guarantees from most of GNT's subsidiaries, as well as personal guarantees from Groza and Naumenko. In January 2021, GNT also obtained a US$20 million working capital facility from Innovatus. GNT repeatedly failed to pay interest on these two loans and failed to repay them at their maturity date in December 2021. When the creditors began to investigate why they were failing to reimburse their debts, an asset dissipation scheme worth millions was revealed. This revelation caused the creditors to enforce to protect their position. The criminal sentencing in the UK is separate to ongoing criminal investigations into fraud and asset stripping alleged to have been undertaken by Groza, Naumenko and certain of their associates including Serbian Dusan Denic and Russian Mikhail Ipatov. Denic is also facing a civil fraud case in New York arising out of his part in the scheme. ENDS Notes to editors: You can find the full judgement here. About Argentem Creek Partners Argentem Creek Partners is an emerging markets specialist investment firm committed to delivering value for investors and partners. The firm seeks to deliver uncorrelated emerging market alpha by investing in special situations, private credit, high yield, trade finance, and bespoke capital solutions. Argentem Creek was founded in 2015 by Daniel Chapman and his former team from Cargill, Inc. subsidiary, Black River Asset Management. https://www.argentemcreek.com About Innovatus Capital Partners, LLC Innovatus Capital Partners, LLC is a New York based registered investment adviser and portfolio management firm with over US$1.8B in assets under management; focused on creating value across special situations, emergent asset classes, private credit and asset-based investments. Innovatus adheres to an investment strategy that identifies disruptive and growth opportunities across multiple asset categories with a unifying theme of capital preservation, income generation, and upside optionality. The Firm has a dedicated team of agriculture finance investment professionals with deep experience in emerging market lending and a strong network of relationships across local contacts and industry participants. www.innovatuscp.com Contact Details Argentem Creek Partners media@argentemcreek.com media@argentemcreek.com Company Website https://www.argentemcreek.com/

October 15, 2024 04:24 AM Eastern Daylight Time

Understanding Wagering Requirements: What Every Player Should Know

Acroud Media

An essential guide to help players make the most of their online casino bonuses. Online casino bonuses can be a great way for players to boost their bankroll and extend their gaming sessions, but understanding the wagering requirements tied to these offers is crucial to making the most of them. In this guide, we break down what wagering requirements are, how they affect your bonus, and what players should know before claiming a bonus. What Are Wagering Requirements? Wagering requirements, often called playthrough or rollover requirements, refer to the number of times players must wager the bonus amount (or the combined deposit and bonus) before they can withdraw any winnings. These conditions are attached to most casino bonuses, such as deposit match offers and free spins. For example, if you receive a £100 bonus with a 20x wagering requirement, you’ll need to bet £2,000 (20 x £100) before you can cash out any winnings associated with the bonus. Wagering requirements are commonly found in free spins no deposit bonuses. You can find out more about the best free spins no deposit bonuses and more on how to navigate wagering requirements here. Why Do Casinos Have Wagering Requirements? Casinos use wagering requirements to prevent players from immediately withdrawing bonus funds without using them for gameplay. These conditions ensure that players engage with the casino and games, balancing the rewards casinos offer with the business's operational sustainability. Types of Bonuses with Wagering Requirements Different types of bonuses come with their own wagering conditions. These include: Deposit Match Bonuses: A percentage of your deposit added as bonus funds (e.g., 100% deposit match up to £200). No Deposit Bonuses: Bonuses offered without requiring an initial deposit, often with higher wagering requirements. Free Spins: Winnings from free spins often have wagering requirements before withdrawal is allowed. Cashback Bonuses: Some cashback offers may include wagering on the bonus funds returned to players. How to Calculate Wagering Requirements Wagering requirements can vary, typically ranging from 20x to 50x the bonus amount. Here's how they work in practice: Bonus Only: If the requirement is applied to the bonus only, you multiply the bonus amount by the requirement. Example: A £50 bonus with a 30x wagering requirement means you need to wager £1,500 (30 x £50). Bonus + Deposit: In some cases, the requirement applies to both the bonus and the deposit. Example: A £50 deposit and £50 bonus with a 30x wagering requirement means you must wager £3,000 ([£50 + £50] x 30). Top Tips for Navigating Wagering Requirements For players looking to maximize their bonus experience, here are some key tips to keep in mind: Read the Terms and Conditions: Always check the wagering requirements and other bonus terms before opting in. Look for hidden details like game restrictions or maximum bet limits. Consider the Wagering Multiplier: Lower wagering requirements (20x-30x) are typically more favorable for players and easier to meet. Higher requirements can make it harder to withdraw winnings. Check Game Contributions: Not all games contribute equally to wagering. Slots often contribute 100%, but table games like blackjack or roulette may only contribute 10% or less. Time Limits: Bonuses often come with time limits for meeting wagering requirements, typically between 7 to 30 days. Make sure you’re aware of how long you have to fulfill the conditions. Know Your Maximum Win: Some bonuses cap the amount you can win or withdraw from bonus funds, so check for any maximum payout limits. What to Look for in a Fair Casino Bonus Not all bonuses are created equal. Players should look for: Reasonable Wagering Requirements: Bonuses with 20x to 40x wagering requirements are considered fair and achievable. Transparency in Terms: The best casinos will clearly state all terms and conditions, including wagering requirements, eligible games, and time limits. No Sticky Bonuses: A “sticky” bonus cannot be withdrawn and is deducted from your balance when you cash out. Avoid these when possible, or ensure you understand their terms. It is important to always gamble responsibly, and seek help via one of the following resources if you feel it is necessary. https://www.gamcare.org.uk/ https://www.nhs.uk/live-well/addiction-support/gambling-addiction/ https://www.gambleaware.org/ Contact Details Acroud Media info-media@acroudmedia.com

October 15, 2024 04:24 AM Eastern Daylight Time

Image

Leaders in The News: BigBear.ai, Luminar, New World Solutions, Tevogen Bio

WSR: BigBear.ai, Luminar, New World Solutions, Tevogen Bio

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: BigBear.ai (NYSE: BBAI), Tevogen Bio (NASDAQ: TVGN), Luminar (NASDAQ: LAZR) and New World Solutions (OTC: REGRF) (CSE: NEWS). Wall Street Reporter highlights the latest comments from industry thought leaders shaping our world today, and in the decades ahead: New World Solutions (OTC: REGRF) (CSE: NEWS) Chairman Jack Marks: ”...Pure Play on $31 Billion Luxury Watch Market” New World Solutions (OTC: REGRF) (CSE: NEWS), majority-owned dialMKT is addressing the digital transformation of the multi-billion dollar global wristwatch enthusiast market by developing a digital ecosystem integrating content, e-commerce, and community.dialMKT’s e-commerce platform is expected to go live within 30 days. The global pre-owned watch market for luxury brands such as Rolex(™), and Patek Philippe(™), is expected to reach $29-32 billion by 2025, according to a recent report from McKinsey & Co. dialMKT CEO and New World Chairman Jack Marks commented “dialMKT already has a fast-growing online community of almost +18,000 users across its website and social media channels, including, YouTube, Instagram, and a growing e-mail newsletter. From our interactions with our community, we know many of these enthusiasts have watch collections worth $50,000 to well over $1 million+. Our business model anticipates that a significant number of our community members will turn into customers on our e-commerce platform to buy, sell and trade their collections - a pipeline for potentially significant revenues in the months ahead". Marks, further noted that (OTC: REGRF) (CSE: NEWS) is “the first and only “pure play” stock focused on the multibillion dollar watch enthusiast market.” Validating the investment thesis of the digital transformation of the watch market, venture capital is flowing into online watch market platforms such as Chrono24, and attracting investors such as Bill Ackman, Jay Z, Tom Brady, Mike Ovitz, Bernard Arnault, Google Ventures and others. New World Solution (OTC: REGRF) (CSE: NEWS) News: https://www.wallstreetreporter.com/2024/09/18/new-world-solutions-cse-news-enters-31-billion-global-watch-market-with-acquisition-of-majority-stake-in-dialmkt/ BigBear.ai (NYSE: BBAI) CEO Mandy Long: “Committed to Digital Transformation of Army” BigBear.ai (NYSE: BBAI) announced that the U.S. Army has awarded the company a five-year, $165.15 million sole source prime contract for Global Force Information Management (GFIM) Production Services. The primary requirement of this contract is to complete the delivery of a dynamic, integrated, and interoperable transactional global force structure and employment data system for the force management community. This system will enable effective planning, programming, and production of authoritative force structure data. BigBear.ai (NYSE: BBAI) CEO Mandy Long commented: "This contract exemplifies our unwavering commitment to the Army’s digital transformation efforts through our deep mission expertise and use of cutting-edge technology." BigBear.ai (NYSE: BBAI) News: https://www.wallstreetreporter.com/2024/10/14/bigbear-ai-nyse-bbai-awarded-5-year-production-contract-valued-at-165-million-to-deliver-the-u-s-armys-global-force-information-management-objective-environment-gfim-oe/ Tevogen Bio (NASDAQ: TVGN) CEO Ryan Saadi: “Drug Development Pipeline With Multi Billion DOllar Revenue Potential” Tevogen Bio (NASDAQ: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to share its $1B+ revenue potential pipeline this week. Tevogen Bio (NASDAQ: TVGN) Ryan Saad Commented: “In the current market reality, Tevogen Bio’s unique, faster, and cost-efficient drug development model has the potential to serve as a blueprint to ensure sustainable medical innovation for years to come. With over three decades of experience in the biopharma industry, Tevogen’s projected multi-billion-dollar revenue reassures me of the company’s strong business fundamentals and its bold, patient-centric drug development strategy, aimed at addressing some of the most pressing health conditions impacting large patient populations" Tevogen Bio (NASDAQ: TVGN) News: https://www.wallstreetreporter.com/2024/10/14/tevogen-bio-nasdaq-tvgn-plans-to-share-1b-revenue-potential-of-its-pipeline-portfolio-beginning-week-of-october-14-2024/ Luminar (NASDAQ: LAZR) CEO Austin Russell: “Luminar Here to Stay and Thrive this Decade.” Luminar (NASDAQ: LAZR), a leading global automotive technology company recently entered into private, separately negotiated transactions to reduce its debt, extend maturities, and receive $100 million in new capital to bolster its balance sheet. This directly addresses the company’s capital structure overhang, captures a discount on existing notes, and helps provide the financial runway to execute the company’s business plan. Luminar (NASDAQ: LAZR) CEO Austin Russell commented: "We’ve now successfully ramped production for the first global production vehicle with standardized LiDAR, and our shift from all eyes on launch towards cost and efficiency are beginning to pay off as we begin to convert our multi-billion-dollar Order Book. This transformational transaction signed today represents a level of conviction from our institutional stakeholders that Luminar is here to stay and thrive this decade. We were able to capitalize on the challenging capital markets conditions in our industry to bolster our balance sheet and raise substantive additional capital from investors to fulfill our business plan." Luminar (NASDAQ: LAZR) News: https://www.wallstreetreporter.com/2024/08/06/luminar-nasdaq-lazr-bolsters-balance-sheet-reports-second-quarter-2024-business-update/ WALL STREET REPORTER Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Issuer sponsored content in this article includes: New World Solutions. Full disclaimer, and relevant SEC 17B disclosures here: https://tinyurl.com/2x4eznd5 About Wall Street Reporter’s Next Super Stock conference: Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/ Rolex (™), Patek Philippe (™), Audemars Piguet (™), Cartier (™) Frank Muller (™) and Richard Mille (™) are licensed trademarks of their respective owners. dialMKT is not an authorized dealer or has any commercial relationship with these brands. Contact Details Wall Street Reporter Wall Street Reporter +1 212-871-2057

October 14, 2024 11:39 AM Eastern Daylight Time

Novidea and Pathpoint Explore E&S Insurance Growth Live at ITC Vegas

Novidea

Novidea, creator of the cloud-based, data-driven enterprise insurance management platform for brokers, agents, MGAs/MGUs, carriers, and wholesalers, and Pathpoint, the modern wholesaler where insurance agents can get bindable, small commercial E&S quotes in just a few minutes, will present a live Q&A at ITC Vegas, the world's largest gathering of insurance innovation. Jeff Heine, Chief Revenue Officer of Novidea, and Alexander Bargmann, CEO and Co-founder of Pathpoint, will present " ITC Brokers: Powering E&S Growth through Strategic Tech Investments," on Tuesday, October 15, 2024, at 11:15 a.m. Pacific Time at ITC Las Vegas at Ballroom F of the Mandalay Bay Convention Center. Pathpoint is one of the fastest-growing Excess & Surplus (E&S) insurance wholesalers in the U.S. Since implementing Novidea's insurance management platform, the company has achieved a 20 percent policy submission growth rate and doubled its sales and underwriting operations to further expand its presence across the country. Novidea's technology enabled the seamless integration of data and applications across Pathpoint's underwriting, account, sales, and operations departments, eliminating data silos and facilitating data-driven decisions about the business. With greater access to customer and operational data across the business, Pathpoint gained greater insights into which lines of business were performing well. They were also able to uncover new opportunities to launch additional risk products in key geographic regions best positioned for growth. "The strategic technology investments we've made over the last few years and the ecosystem we've built have been instrumental in our growth strategy," Bargmann said. "I'm looking forward to joining Jeff Heine of Novidea on stage at ITC to share the Pathpoint story. I hope to inspire and educate other E&S and intermediary insurance leaders with valuable advice that they can implement in their own organizations." Experts across the insurance industry predict the E&S segment will outpace the overall commercial lines market within the next few years. E&S saw double-digit, year-over-year growth for four consecutive years. To support this unprecedented growth, E&S brokers and agents must make investments in modern, highly scalable technology so they can keep up with demand and respond faster. "Novidea research shows that 49% of insurance business decision-makers say enabling growth is the number one priority when choosing a new technology. E&S and the broader intermediary market that lack modern technology systems to help them streamline processes at scale will lose out on the massive growth potential this sector is experiencing," said Jeff Heine, CRO at Novidea. "In our presentation at ITC, Alex and I will talk about the need for agile, cloud-native technologies that deliver a great digital experience while eliminating the need for agents to re-key information or fill out clunky forms. We will show how speed, accuracy, efficiency, and scale are the keys to success for E&S players like Pathpoint." In addition to the presentation, Novidea is a sponsor and exhibitor at ITC Vegas. For more information about Novidea's award-winning technology, visit ITC booth number #2365 or visit www.novidea.com. About Novidea Novidea is the leading Insurtech provider of a cloud-native, data-driven insurance management system. With its open API architecture, Novidea enables brokers, agents, MGAs, and carriers to modernize and manage the customer journey end-to-end and drive growth across the entire insurance distribution lifecycle. Novidea's streamlined and automated platform fully integrates front, middle, and back offices. The Novidea platform boosts operational efficiency while providing a seamless digital experience for team members and customers alike. Insurance businesses benefit from a 360-degree view of customers and policies and can access data and actionable insights anytime, anywhere, and on any device. Novidea supports more than 100 customers across 22 countries. For more information, visit www.novidea.com. About Pathpoint Pathpoint is the modern wholesaler where insurance agents can get bindable small commercial E&S quotes in just a few minutes. Pathpoint combines proprietary technology and first-class service to enable strategic partners to give retail insurance agents fast access to quotes from multiple, A-rated carriers in the contractors, vacants, lessor's risk, monoline property, restaurants, and cyber verticals. Pathpoint is licensed in all 50 states and a coverholder at Lloyd's of London. To learn more about Pathpoint, and become a strategic partner, visit www.pathpoint.com. Contact Details Michelle Barry +1 603-809-2748 Michelle.barry@chameleon.co Company Website https://novidea.com/

October 14, 2024 11:00 AM Eastern Daylight Time

This Company Is Saving Lives With Personal Emergency Response Systems

Benzinga

By Johnny Rice, Benzinga Chia-Lin Simmons, CEO of LogicMark (NASDAQ: LGMK), was recently interviewed by Benzinga. LogicMark is a cutting-edge provider of personal emergency response systems (PERS), health communications devices and IoT technologies. CEO Chia-Lin Simmons spoke about the company and its growth strategies aimed at increasing shareholder value. She discussed her efforts to turn the company around, shifting from a one-time purchase hardware model to a SAAS and recurring revenue model. Additionally, she talked about LogicMark’s expansion into personal safety, not just for aging adults but for all. Watch the full interview here: Featured photo by Piotr Chrobot on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 14, 2024 09:15 AM Eastern Daylight Time

Video Image

MSTU And MSTZ: The Only 2x ETFs On MicroStrategy And One Of The Most Volatile Ways To Play Bitcoin

Benzinga

By Gerelyn Terzo, Benzinga As the Bitcoin price dances in the $60,000s, investors are reminded of an effectively inherent element – volatility. Now that Bitcoin has become mainstream, investors and traders have more ways than ever to gain exposure to this digital currency. They are no longer limited to buying and holding in dedicated crypto wallets or exchanges, thanks to a combination of regulatory tailwinds and tech innovation that has opened up the world of crypto directly within brokerage accounts. While many people are focusing on Spot Bitcoin ETFs, one of the most interesting ways to capitalize on this opportunity includes listed companies that are piling Bitcoin onto their balance sheets, such as MicroStrategy (NASDAQ: MSTR). The company's strategic decision to invest heavily in Bitcoin ties its stock performance closely to the digital currency's price swings. As a result, trading in MicroStrategy shares effectively becomes a play on Bitcoin's infamous volatility. This has particularly appealed to traders who seek exposure to Bitcoin's potential upsides and inherent risks, while also leveraging the liquidity and regulatory framework of a NASDAQ-listed stock. MicroStrategy's own implied volatility is a potentially attractive feature for those looking to benefit from rapid price changes in the crypto market, magnified by the company's significant Bitcoin holdings. With an average daily trading volume of 11 million shares in September, MicroStrategy stock offers no shortage of opportunities. And now one way to play MicroStrategy with leverage is through a pair of ETFs launched by REX Shares — which recently surpassed $5 billion in assets under management — alongside ETF provider Tuttle Capital Management. Now, REX Shares and Tuttle Capital have launched the industry’s only 2x/-2x ETFs for MicroStrategy - T-REX 2X Long MSTR Daily Target ETF (BATS: MSTU) and T-REX 2X Inverse MSTR Daily Target ETF (BATS: MSTZ). REX’s ETFs are the first of their kind to offer +200% and -200% exposure to MicroStrategy, reports REX Shares, potentially paving the way for traders who closely monitor MSTR stock movements to harness fresh possibilities. Each of REX’s latest products gives investors a way to play both sides of the coin. For example, the T-REX 2X Long MSTR Daily Target ETF was created for traders who are bullish on MSTR shares, delivering the potential to amplify gains with +200% exposure to the stock’s daily movements. On the flip side, the T-REX 2X Inverse MSTR Daily Target ETF offers 200% inverse exposure to MSTR, offering traders who are bearish on MicroStrategy’s stock price to bet on its decline. With the options market now open, investors can take their trading strategies a step further by utilizing options to fine-tune their positions, hedge risk or capitalize on market volatility, said REX Shares. With the opportunities that options trading can provide, coupled with ETFs and Bitcoin, investors have no shortage of ways to play this dynamic market that is ripe with volatility. To explore REX’s approach to trading, check out its product offerings here. REX’s ETF Appeals To Bulls And Bears Options give traders the opportunity to purchase contracts that give them the right to buy or sell an asset, like a stock or cryptocurrency, for a pre-set price over a specified term. Options trading has taken hold in the Bitcoin market, where monthly expiry amounts on BTC contracts have been ranging from $8 billion to $14 billion since the flagship cryptocurrency’s most recent halving event. After recently introducing the first and only 2x leveraged MSTR ETFs to the market, REX Shares says it will continue to innovate, essentially giving sophisticated traders a chance to place leveraged wagers on Bitcoin, of which MicroStrategy owns over $9 billion worth, as of September. Given MicroStrategy’s commitment to owning Bitcoin, its stock is often as volatile as the cryptocurrency itself. Investors should be aware that trading these funds is not the same as investing directly into Bitcoin or MicroStrategy, commanding a heightened level of portfolio management. You can learn more about these ETFs as well as other trading products that REX Shares has to offer here. Featured photo by Tyler Prahm on Unsplash Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 14, 2024 09:05 AM Eastern Daylight Time

Image

Tesla Seems To Be Having Trouble Building A Better Battery – Could This Company Solve The Problem?

Benzinga

By Johnny Rice, Benzinga Denis Phares, CEO of Dragonfly Energy (NASDAQ: DFLI), was recently a guest on Benzinga’s All-Access. Dragonfly Energy is a leading green energy storage company. The company reports that it develops some of the most popular Lithium-ion battery products in the RV and Marine industries today, through the Battle Born Batteries brand. Dragonfly is committed to pushing the industry forward and helping onshore manufacturing back to the U.S. Mr. Phares spoke about the company’s process and how it could help Tesla (NASDAQ: TSLA) solve its production woes. Watch the full interview here: Featured photo by Possessed Photography on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 14, 2024 09:02 AM Eastern Daylight Time

Video Image

VTS Recognized on Commercial Observer’s Annual Power Proptech List For Third Consecutive Year

VTS

VTS, the industry's only technology platform that unifies owners, operators, brokers, and their customers across the real estate ecosystem, today announced that Commercial Observer has recognized CEO Nick Romito, Chief Strategy Officer Ryan Masiello, and Chief Technology Officer Swaroopa Penikelapati in its third annual Power Proptech List. “We’ve seen immense product-led growth in 2024, and our recognition as a power player in proptech is a testament to all of the hard work our team at VTS has invested since day one,” said Nick Romito, CEO of VTS. “We look forward to maintaining our position at the forefront of industry transformation and to continue pushing the boundaries of innovation for real estate.” Under Romito, Masiello, and Penikelapati’s leadership, VTS has celebrated numerous company milestones in the past year and continued to expand its platform’s capabilities. In March 2024, VTS announced the launch of VTS 4, the company’s novel predictive analytics solution powered by the newly developed VTS Demand Model. Along with the launch of VTS 4, VTS expanded its VTS Data offering to the London market, bringing commercial real estate’s only real-time data and insights to the United Kingdom. In April 2024, the company announced it would be expanding into the multifamily sector with the launch of its resident experience offering, VTS Activate Multifamily, and major residential industry players Lendlease, Habitat, and Stonehenge all selected and deployed it as their resident experience solution of choice. In May 2024, VTS introduced VTS Activate Workplace, the first workplace experience solution that can combine native workplace and building systems into one application. VTS continues to be a trusted source for industry data, with its quarterly VTS Office Demand Index (VODI) and annual Global Landlord Report. In February 2024, VTS introduced its Global Workplace Report, which leverages data to pinpoint corporate tenant needs and expectations related to office space. “We’re honored to be recognized once again on Commercial Observer’s Power PropTech list,” said Ryan Masiello, Chief Strategy Officer at VTS. “At VTS, we have always focused on anticipating industry needs and delivering solutions that drive meaningful impact for both landlords and tenants. We remain committed to being a leader in proptech, and are incredibly excited for what the future holds for both VTS and the real estate industry at large.” "I’m thrilled to be recognized by the Commercial Observer in their annual Power Proptech List alongside Nick and Ryan, as well as other innovators in the proptech space” said Swaroopa Penikelapati, Chief Technology Officer at VTS. “VTS is committed to innovation by driving meaningful outcomes through our technology and solving problems for our customer base. I look forward to continuing to push the boundaries of what our platform can deliver and drive maximum value for our customers.” Commercial Observer’s annual Power Proptech List is a compilation of the most influential individuals in the rapidly evolving world of proptech. In a field that continues to undergo significant transformation, this list recognizes executives and companies that shape the industry and possess the resilience and innovation necessary to thrive in changing times. About VTS VTS is the commercial real estate industry’s only technology company that unifies owners, operators, brokers, and tenants in a single platform to capitalize on opportunities revealed in every square foot of their properties. In 2013, VTS revolutionized the commercial real estate industry’s leasing operations with what is now VTS Lease. Today, the VTS Platform is the largest first-party data source in the industry, transforming how strategic decisions are made and executed by CRE professionals across the globe. With the VTS Platform, consisting of VTS Lease, VTS Activate, VTS Data, and VTS Market, every business stakeholder in commercial real estate is given real-time market information and workflow tools to do their job with unparalleled speed and intelligence. VTS is the global leader, with more than 60% of Class A office space in the U.S., and 12 billion square feet of office, retail, and industrial space is managed through our platform worldwide. VTS’ user base includes over 45,000 CRE professionals and industry-leading customers such as Blackstone, Brookfield Properties, LaSalle Investment Management, Hines, BXP, Oxford Properties, JLL, and CBRE. To learn more about VTS, and to see our open roles, visit www.vts.com. Contact Details Sofia Chevez +1 646-912-5354 schevez@marinopr.com Company Website https://www.vts.com/

October 14, 2024 09:00 AM Eastern Daylight Time

1 ... 32 33 34 35 36 ... 3771